AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
Stay updated with breaking news from Maria Backlund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, today announced that an abstract on its preclinical project TrkA-NAM against osteoarthritis pain and other severe pain conditions has been accepted for presen...
AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that a new scientific article on preclinical results supporting a disease-modifying effect with NeuroRestore ACD856 has been made available online.
STOCKHOLM, SWEDEN / ACCESSWIRE / March 30, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
AlzeCure Presents New Data at Alzheimer’s Conference AD/PD on the Potential ...